Objekt-Metadaten

The role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells
Redmer, T. ;  Walz, I. ;  Klinger, B. ;  Khouja, S. ;  Welte, Y. ;  Schaefer, R. ;  Regenbrecht, C.

HaupttitelThe role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells
AutorRedmer, T.
AutorWalz, I.
AutorKlinger, B.
AutorKhouja, S.
AutorWelte, Y.
AutorSchaefer, R.
AutorRegenbrecht, C.
Seitenzahl13 S.
DDC610 Medizin und Gesundheit
Auch erschienen inOncogenesis. - 6 (2017), 1, Artikel Nr. e291
ZusammenfassungSeveral lines of evidence have suggested that stemness and acquired resistance to targeted inhibitors or chemotherapeutics are mechanistically linked. Here we observed high cell surface and total levels of nerve growth factor receptor/CD271, a marker of melanoma-initiating cells, in sub-populations of chemoresistant cell lines. CD271 expression was increased in drug-sensitive cells but not resistant cells in response to DNA-damaging chemotherapeutics etoposide, fotemustine and cisplatin. Comparative analysis of melanoma cells engineered to stably express CD271 or a targeting short hairpin RNA by expression profiling provided numerous genes regulated in a CD271-dependent manner. In-depth analysis of CD271-responsive genes uncovered the association of CD271 with regulation of DNA repair components. In addition, gene set enrichment analysis revealed enrichment of CD271-responsive genes in drug-resistant cells, among them DNA repair components. Moreover, our comparative screen identified the fibroblast growth factor 13 (FGF13) as a target of CD271, highly expressed in chemoresistant cells. Further we show that levels of CD271 determine drug response. Knock-down of CD271 in fotemustine-resistant cells decreased expression of FGF13 and at least partly restored sensitivity to fotemustine. Together, we demonstrate that expression of CD271 is responsible for genes associated with DNA repair and drug response. Further, we identified 110 CD271-responsive genes predominantly expressed in melanoma metastases, among them were NEK2, TOP2A and RAD51AP1 as potential drivers of melanoma metastasis. In addition, we provide mechanistic insight in the regulation of CD271 in response to drugs. We found that CD271 is potentially regulated by p53 and in turn is needed for a proper p53-dependent response to DNA-damaging drugs. In summary, we provide for the first time insight in a CD271-associated signaling network connecting CD271 with DNA repair, drug response and metastasis.
Dokumente
PDF-Datei von FUDOCS_document_000000026934
Falls Ihr Browser eine Datei nicht öffnen kann, die Datei zuerst herunterladen und dann öffnen.
 
Fachbereich/EinrichtungMedizinische Fakultät Charité - Universitätsmedizin Berlin
Erscheinungsjahr2017
Dokumententyp/-SammlungenWissenschaftlicher Artikel
SpracheEnglisch
RechteCreative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Anmerkungen des AutorsDer Artikel wurde in einer reinen Open-Access-Zeitschrift publiziert.
Erstellt am02.05.2017 - 11:39:08
Letzte Änderung02.05.2017 - 11:40:44
 
Statische URLhttp://edocs.fu-berlin.de/docs/receive/FUDOCS_document_000000026934
DOI10.1038/oncsis.2016.88
Zugriffsstatistik
 

LOADING...